Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hematron
- Development stage
- Unknown
- Lead developer
- Seyer Pharmatec
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Hematron (also marketed as Hematron-AF) is a multi-vitamin and multi-mineral dietary supplement developed and marketed by Seyer Pharmatec, Inc. It is specifically indicated for improving the nutritional status of patients with iron deficiency and is utilized as a supportive care product in cancer treatment to address anemia and other hematologic complications. The formulation includes a combination of carbonyl iron, ascorbic acid (vitamin C), dl-alpha tocopheryl acetate (vitamin E), L-5-methyltetrahydrofolate calcium (folate), cyanocobalamin (vitamin B12), biotin, and cupric sulfate (copper). By providing these essential nutrients, Hematron supports hemoglobin synthesis and erythropoiesis, helping to manage common side effects of oncological therapies. It is available as an oral tablet and is manufactured in the USA for Seyer Pharmatec.
- Brand names
- HematronHematron-AF
02
Targets
DNA
Beyond the preview
Go deeper on Hematron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hematron.